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Abstract
Type 2 Diabetes (T2D) is a highly prevalent chronic metabolic disease with strong co-morbidity with obesity and
cardiovascular diseases. There is growing evidence supporting the notion that a crosstalk between mitochondria and the
insulin signaling cascade could be involved in the etiology of T2D and insulin resistance. In this study we investigated the
molecular basis of this crosstalk by using systems biology approaches. We combined, filtered, and interrogated different
types of functional interaction data, such as direct protein–protein interactions, co-expression analyses, and metabolic and
signaling dependencies. As a result, we constructed the mitochondria-insulin (MITIN) network, which highlights 286 genes
as candidate functional linkers between these two systems. The results of internal gene expression analysis of three
independent experimental models of mitochondria and insulin signaling perturbations further support the connecting roles
of these genes. In addition, we further assessed whether these genes are involved in the etiology of T2D using the genome-
wide association study meta-analysis from the DIAGRAM consortium, involving 8,130 T2D cases and 38,987 controls. We
found modest enrichment of genes associated with T2D amongst our linker genes (p=0.0549), including three already
validated T2D SNPs and 15 additional SNPs, which, when combined, were collectively associated to increased fasting
glucose levels according to MAGIC genome wide meta-analysis (p=8.12610
25). This study highlights the potential of
combining systems biology, experimental, and genome-wide association data mining for identifying novel genes and
related variants that increase vulnerability to complex diseases.
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Introduction
Insulin resistance is a common trait present in complex
disorders such as type 2 diabetes (T2D), obesity or metabolic
syndrome (MetS). Around 340 million people suffer from diabetes
worldwide, 90% of whom have T2D (http://www.who.int/
diabetes/facts/en). Unlike type 1 diabetes, overt T2D is usually
diagnosed several years after its onset due to its milder presenting
symptoms, which in part explains why several devastating
complications such as cardiovascular related diseases tend to
develop soon after or have already arisen at the moment of the
initial diagnosis.
PLOS Genetics | www.plosgenetics.org 1 December 2012 | Volume 8 | Issue 12 | e1003046There has been growing interest in identifying genes and
processes that could trigger insulin resistance beyond defects on
the insulin signaling cascade itself. As a result, defective
mitochondrial activity has been indirectly related to insulin
resistance in insulin-targeted tissues, such as skeletal muscle
[1,2,3] and liver [4]. In particular, patients with T2D and, more
importantly, non-diabetic subjects with type 2 diabetic relatives
showed mitochondrial dysfunction and lower expression of PPAR
gamma co-activator 1 alpha and 1 beta (PGC-1a and PGC1-1b),
which are key regulators of mitochondrial biogenesis and function.
In addition, subjects with early-onset type 2 diabetes typically
show defective activation of PGC-1alpha in response to physical
activity [5], and similarly, morbid obese type 2 diabetic patients
show a defective activation of mitochondrial gene expression in
response to weight-loss surgery [5]. Whether there is a heritable
component involved in the alterations in expression of mitochon-
drial genes/proteins in these common forms of T2D remains to be
determined.
Despite all of these efforts and lines of evidence, the mechanisms
and the molecular contributors to the connection between
mitochondria and the insulin signaling and resistance are still
unknown. The availability of a wide range of functional
interaction data, including metabolomics, genomics, transcrip-
tomics and proteomics and the integration of all these data using
systems biology approaches make it now possible to investigate in
detail the molecular basis of the interaction between the insulin
signaling cascade and mitochondrial biology in healthy and
pathological scenarios, particularly in the context of T2D.
In addition, and despite substantial progress achieved in the
identification of candidate genes involved in specific complex
processes or diseases through genome-wide association studies
(GWAS), for most diseases, including T2D, less than 10% of the
heritability (percentage of variance attributable to genetic varia-
tion) can be explained by the identified genetic associations [6].
Some hypotheses suggest that a portion of the missing heritability
stays behind multiple small effect size variants that have not yet
reached genome-wide significance in GWAS meta-analyses when
tested individually, due to insufficient sample sizes. If many of the
modest effect variants are assumed to implicate genes that function
in a limited number of biological processes, collective analysis of
variants based on prior biological knowledge could substantially
enhance association detection power. In that sense, the application
of systems biology approaches to analyze GWAS data may have
the potential to increase the chances of unraveling susceptibility
genes or biological processes for complex diseases.
In this study, we applied systems biology approaches to screen
and identify novel candidate T2D genes. The search has been
guided by the hypothesis that the functional components of the
crosstalk between the insulin signaling pathway and the biology of
the mitochondria may play a role in the etiology or the evolution
of the disease. We have also generated and analyzed gene
expression data on insulin resistance and mitochondria perturbed
scenarios to support these candidate genes. We finally tested
whether particular genetic variants in loci that contain the
identified genes could be collectively associated with T2D.
Results
Generation of the MITIN network
In order to identify genes specifically involved in the crosstalk
between the insulin signaling pathway and the mitochondria, we
looked for all possible direct and indirect functional interactions
between mitochondria and insulin signaling genes (Figure 1). We
started by building reliable models and parts lists for these two
systems. We first explored and manually filtered several public
versions of the insulin signaling pathway to end up with a
confident collection of 197 proteins/genes (see Methods). At the
same time, we extracted data from a database of nuclear and
mitochondrial-encoded mitochondrial proteins (MitoP2) to gener-
ate the corresponding list of 682 mitochondria genes [7].
Once both parts lists were constructed, we screened several
large functional interaction databases to identify direct and
indirect connections involving any of the protein/genes of each
of the systems. We applied several filters and cutoffs to be able to
isolate, from all available interactions, a reliable collection that will
be used further in our study. For example, from protein-protein
interaction (PPI) data, we only considered those protein pairs
whose interactions were reported by two or more independent
laboratories (PPIhigh) and whose pair of genes were reported to be
expressed both in any of the insulin-sensitive tissues (adipose tissue,
muscle, liver and heart, [8]); or any other PPI interaction reported
only by a single laboratory, simultaneously expressed in any of the
insulin-sensitive tissues and that also showed co-expression (gene-
expression correlation) in a dataset of 427 healthy human liver
samples [9] (these interactions are here termed PPIcorr). As a third
layer of functional interaction, we also linked those proteins
observed to belong to the same protein complex as described in
the CORUM protein complex database [10]. The fourth source of
interaction consisted of pairs of genes coding for enzymes that
participate in linked metabolic reactions, i.e. those reactions that
are adjacent in a metabolic reaction map according to the
Biochemical Genetic and Genomic (BiGG_met) and the Kyoto
Encyclopedia of Genes and Genomes database (http://www.
genome.jp/kegg/kegg2.html; KEGG_met) [11,12,13]. Finally, we
also included those interactions between genes coding for
complexes or genes linked in a signaling pathway, as defined by
KEGG (KEGG_path) [12]. This final functional interactome
comprised 57,751 high confidence functional interactions involv-
ing 6963 genes, which represent a whole functional network of
insulin-targeted tissues or cells.
From the pool of selected high quality interactions (affecting
6963 genes), we finally selected those interactions that, either
Author Summary
It has been shown that the crosstalk between insulin
signaling and the mitochondria may be involved in the
etiology of type 2 diabetes. In order to characterize the
molecular basis of this crosstalk, we mined and filtered
several interaction databases of different natures, includ-
ing protein–protein interactions, gene co-expression,
signaling, and metabolic pathway interactions, to identify
reliable direct and indirect interactions between insulin
signaling cascade and mitochondria genes. This allowed us
to identify 286 genes that are associated simultaneously
with insulin signaling and mitochondrial genes and
therefore could act as a molecular bridge between both
systems. We performed in vitro and in vivo experiments
where the insulin signaling or the mitochondrial function
were disrupted, and we found deregulation of these
connecting genes. Finally, we found that common variants
in genomic regions where these genes lie are enriched for
genetic associations with type 2 diabetes and glycemic
traits according to large genome-wide association meta-
analyses. In summary, we reconstructed the network
implicated in the crosstalk between the mitochondria
and the insulin signaling and provide a list of genes
connecting both systems. We also propose new potential
type 2 diabetes candidate genes.
Mitochondria–Insulin Crosstalk T2D Candidate Genes
PLOS Genetics | www.plosgenetics.org 2 December 2012 | Volume 8 | Issue 12 | e1003046directly or indirectly, provide a link between the mitochondrial
and the insulin signaling cascade genes. We defined indirect
interactions as those mediated by genes, termed linker or
internode genes, that do not belong to either the insulin or the
mitochondria parts list, but that are simultaneously connected to
both systems. By applying these filters, we finally generated the
mitochondria-insulin (MITIN) network consisting of 886 genes
and a total of 1259 interactions, 70 direct (Table S1) and 1194
indirect. The 70 direct interactions involved 44 insulin genes and
37 mitochondria genes, most of them showing only one evidence
of interaction. Both the insulin and mitochondria genes that were
directly connected were linked to a median of two genes from the
other system. Direct connections showed heterogeneous sources of
interaction: PPIhigh, PPIcorr, Corum Complexes, BiGG_met,
KEGG_met, Kegg_pathway, contributed 41, 9, 13, 2, 3, 12 links,
respectively. Indirect interactions involved 286 linker internode
genes (Figure S1, Dataset S1, Table S2 and S3). These internodes
genes were connected to a mean number of 2.1 Insulin and 1.7
mitochondria genes and showed a mean of 2.6 and 2.0 lines of
evidence of interaction with insulin and mitochondria, respective-
ly. Regarding the 1194 indirect connections, PPI, PPIcorr, Corum
Complexes, BiGG_met,KEGG_met, Kegg_pathway, contributed
570, 472, 1263, 42, 160, 169 interactions, respectively.
While the majority of the internode genes seem to be novel, as
their bridging role connecting both systems has not yet been
described, some of them have already been shown to interact with
both systems, which constitutes an internal positive control of our
underlying search methodology. For example, TRAF2 shows
interactions within our MITIN network with four insulin and two
mitochondrial genes (Table 1). Interestingly, other independent
studies and approaches also identified five of these interactions. In
particular with MAP3K1 (MEKK1), CAV1 (caveolin-1) and
MTOR (mTOR), from the insulin signaling [14,15,16] and
MAP3K5 (ASK1) and CASP8 (caspase-8) from the mitochondria
[17,18] (Figure 2). Another example is NFKB1, for which we
found interactions with four insulin signaling and three mitochon-
drial genes. As above, NFKB1 has been also reported to interact
with the IKBKB [19,20], AKT2 [21], MAP3K1 [22] and SOCS3
insulin genes, as well as to BCL2L1 [22] [23] and BCL2 [24]
(Figure 2).
Figure 1. Schematic flow chart of the generation and evaluation of the MITIN network. The different sources of functional interaction are
combined to generate a functional interactome. The resulting network is used to identify the direct and indirect interactions between the insulin
signaling and mitochondria systems. The relevance of the MITIN network is tested analyzing gene expression data of models perturbing either insulin
signaling or mitochondria function, and testing the variability within or near the MITIN network genes using GWA meta-analyses from DIAGRAM
consortium. *In all PPIhigh and PPIcorr, both pair of interacting proteins have to be simultaneously expressed in any of the insulin-targeted tissues
(adipose tissue, muscle, liver and heart).
doi:10.1371/journal.pgen.1003046.g001
Mitochondria–Insulin Crosstalk T2D Candidate Genes
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PLOS Genetics | www.plosgenetics.org 4 December 2012 | Volume 8 | Issue 12 | e1003046The same MITIN network also allowed us to define which
mitochondrial genes are more connected to insulin signaling, and
vice-versa, either directly or indirectly. The top five insulin signaling
genes most connected to mitochondria are NOLC1, RPS6, IKBKB,
PKLR, SRC, with a total of 99, 40, 31, 28 and 22 indirect
connections with mitochondria, respectively. Similarly, the five
most connected mitochondrial genes with the insulin cascade were
TUFM, TP53, SLC25A5, POLG, ESR1, with a total of 93, 36, 29,
25, and 19 indirect connections, respectively (Table S4).
We next explored whether our collection of internode genes
where enriched in particular functions or processes by querying
the Molecular Signatures Database [25]. We found up to 148
functional signatures for which internode genes were significantly
enriched (5.7610
2107,p value,4.41610
26, 1.94,Odds ra-
tio,20.1; Table S5). Besides several enriched categories related
to translation, Reactome Regulation of Expression in Beta Cells
(p=3.5610
287, Odds Ratio=15.8), Reactome Insulin Synthesis and
Secretion (p=4.46610
279, Odds ratio=14.0), and Reactome Diabetes
pathways (p=1.39610
235, Odds ratio=5.5) were also highly
enriched among our set of internode genes. No significant
categories were found after correcting for multiple testing in a
set of internode genes identified from a simulated network made of
randomly generated interactions.
In order to facilitate the selection of any of these genes for
further studies, we have ranked them according to their number of
connections to each of the systems. Hence, we provide a confident
subset of 31 genes with at least three lines of evidence linking
insulin signaling and mitochondria genes simultaneously (Table 1).
Internode gene expression is altered in insulin resistance
and mitochondrial dysfunction experimental models
As further support of the functional relationship between
internode genes and both, the mitochondria and the insulin
signaling pathway, we explored whether the expression of these
identified internode genes is modified after perturbing each of the
mitochondria or insulin signaling systems independently.
To test the effect of the insulin signaling perturbation, we
performed gene expression profiling of C2C12 differentiated
myotubes that were either left untreated or treated with 100 nM
insulin for 2 days in order to induce an insulin resistance state.
This treatment resulted in the downregulation of the insulin
receptor and subsequently significantly reduced insulin signaling
cascades [26]. We used the gene set enrichment analysis method
(GSEA, [25]) to look for enrichment of differential expression
using our set of internode, mitochondria, and insulin genes as
molecular signatures. Using the collection of all 6963 genes with
identified interactions as a background, we found significant
enrichment of upregulation within the internode genes (Normal-
ized Enrichment Score (NES)=1.7; False Discovery Rate
(FDR)=0.0013), while observed downregulation enrichment
within the insulin signaling genes (NES=21.4; FDR=0.028)
(Figure 3a). We also explored a second model of insulin signaling
cascade perturbation through the analysis of transcriptome data
from myotubes treated with RNAi against DOR (also named
Tp53inp2). This gene is dysregulated in muscle of Zucker diabetic
rats, participates in the myogenic differentiation and mediates a
feed-forward loop between ecdysone receptor and the insulin
signaling in flies [27,28]. In this model, we also found that there
was an enrichment of upregulated internode genes (NES=1.4;
FDR=0.004) and enrichment of downregulated insulin
(NES=21.35; FDR=0.007) and mitochondrial (NES=21.36;
FDR=0.001) genes (Figure 3c).
In a parallel experiment we tested how perturbations of
mitochondria affect the expression of the MITIN network genes.
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PLOS Genetics | www.plosgenetics.org 6 December 2012 | Volume 8 | Issue 12 | e1003046For this, we analyzed gene expression from the heart of
Peroxisome-proliferator-activated-receptor c coactivator 1 beta
(PGC-1b) knock-out mice. PGC-1b is a co-activator that regulates
mitochondrial biogenesis and function [29,30,31,32]. The analysis
of heart gene expression of these mice showed an overrepresen-
tation of upregulated genes within the internodes (NES=1.3;
Figure 3. Gene set enrichment analysis. Gene set enrichment analysis of models with impaired Insulin (a, c) or mitochondrial (b) function. In all
cases there was enrichment of upregulated genes within the internodes, except for the case when internodes were generated from a random
network (d).
doi:10.1371/journal.pgen.1003046.g003
Figure 2. Connections of two internode genes, TRAF2 and NFKB1, with insulin genes and mitochondria genes. Two strong candidates
linking both insulin and mitochondria genes from Table 1 were chosen and their connections to insulin genes and mitochondria genes verified using
literature published in the PubMed. See main text for detailed description. A) TRAF2 has been reported to be connected to MAP3K1 (MEKK1) and
CAV1 (caveolin 1) insulin genes, and to MAP3K5 (ASK1) and CASP8 (caspase-8) mitochondrial genes. A possible connection to MTOR (mTOR) has also
to be considered. MAP3K5=ASK1; MAP3K1=MEKK1. B) NFKB1 (NF-kB1) is connected to IKBKB (IKKb), AKT2, MAP3K1 and SOCS3 insulin genes, and
BCL2 and BCL2L1 mitochondrial genes. NFKB1=NFKBp50; IKBKB=IKKb=IKK2; MAP3K1=MEKK1; P65=RelA. Green boxes represent insulin genes
reported to interact with TRAF2 or NFKB1 according to our network; and light-blue represents mitochondrial genes reported to interact with TRAF2
or NFKB1 according to our network. Yellow boxes represent insulin signaling genes.
doi:10.1371/journal.pgen.1003046.g002
Mitochondria–Insulin Crosstalk T2D Candidate Genes
PLOS Genetics | www.plosgenetics.org 7 December 2012 | Volume 8 | Issue 12 | e1003046FDR=0.02), enrichment of upregulated genes within the insulin
genes (NES=1.6; FDR=0.0012), and enrichment of downregu-
lated mitochondria genes (NES=22.63; FDR=,0.0001)
(Figure 3b). Again, as a control from our experiment, randomly
generated internode genes did not show any enrichment in any of
these experiments (Figure 3d).
Clinical implications of the Global MITIN Network
We next investigated whether any of these genes has been
associated to phenotypes related to insulin resistance or energy
metabolism. For this, we searched through the OMIM database
(http://www.ncbi.nlm.nih.gov/omim) those internode genes that
are involved in mendelian and complex disorders [33].
We found that, among all 286 internode genes, 191 (66%) were
in genomic loci associated to complex diseases or traits (SNPs
within 250 kb from internode gene were considered) and 17 (6%)
were involved in mendelian diseases. Interestingly 53 of the genes
(18%) contained or were near polymorphisms associated to T2D
or related traits such as obesity, adiposity, response to glucose
challenge, hypertension or coronary artery disease (Table S6).
10,000 random simulations showed that finding 53 genes
associated to T2D related traits was modestly more than what
expected by chance (p=0.0535). In contrast, the 10,000 random
simulations also showed that we did not find more associations
with any complex trait (not restricting to T2D related traits), than
would be expected by chance, suggesting that the enrichment for
associations of the identified internode genes is specific for T2D
and related metabolic traits.
Scanning T2D genome-wide association meta-analyses
for variants in the internode genomic regions shows
enrichment of T2D associations
In order to further investigate the potential involvement of the
internode genes in the etiology of T2D, we screened the
DIAGRAM consortium GWAS dataset, which consisted on the
largest T2D meta-analysis available at the time of the study
(DIAGRAM meta-analysis): 8,130 cases and 38,987 controls [34].
To analyze enrichment of associated genes within the internodes,
we used MAGENTA [35], a software specifically designed for
large genome-wide association study meta-analyses, where indi-
vidual genotypes are typically not available. We found that our
internode gene list showed nominal enrichment for modest to
strongly associated genes within the top 5% of T2D scores, with 18
genes observed, including three already confirmed T2D associated
SNPs [34,36,37], compared to the 12 expected by chance
(p=0.0549, Table 2). These results were robust to the enrichment
cutoff used (p=0.0368 when testing for enrichment above the
97.5th percentile of all gene scores; 6 genes expected above cutoff,
11 observed). Unlike the collection of internode genes, no
significant enrichment for T2D associations was found for gene-
sets belonging only to the insulin signaling (p=0.71) or to the
mitochondrial (p=0.52) systems. The insulin and mitochondria
genes directly interacting with each other were also not enriched
for T2D associations (p=0.53).
To further support the involvement of at least some of these 18
internode SNPs in glucose metabolism regulation, we also
computed how the best associated SNPs in the 18 regions
increased the risk of altered glycemic traits, available from
MAGIC consortium datasets [38,39,40,41,42], using an approx-
imation approach developed by Toby Johnson [43]. Among the
seven traits tested, we found a significant association risk score for
fasting glucose (p=8.12610
25 including the 18 top ranked SNPs
and p=0.004 including 15 out of the 18 SNPs not previously
associated with T2D). In order to evaluate the probability of
finding such a highly statistical p-value, when using the top T2D
associated genes (and best local SNPs) we ran MAGENTA on
10,000 simulated random gene-sets, and extracted for each
simulation the p-values of the most significant SNP per gene for
all genes that ranked above the 95th percentile. The empirical p-
value was then calculated as the frequency of random gene-sets
whose p-values were smaller than the one obtained with the real
data and whose effect size was higher than 0. We found that
8.12610
25 is significantly lower than what one can expect by
chance (p=0.0144), confirming the association of our set of
internode genes, not only with T2D, but also to fasting glucose
levels.
Genetic variants in internode genomic regions associated
with T2D are also associated with metabolic related
quantitative traits
To further explore the involvement of the internode genes
associated with T2D (see above) in related metabolic traits we
explored several available GWA meta-analyses pertaining to
obesity-related traits from the GIANT consortium [44,45], seven
glycemic traits from MAGIC datasets [38,39,40,41,42], and
cardiovascular disease traits from the ICBP consortium [46]. We
found that in 10 of the 18 internode genomic loci with modest to
strong associations, there was at least one SNP showing association
(p,10
25) to one of these metabolic traits. For example,
rs6453220, located in the IQGAP2 intron, was associated to
circulating glycated hemoglobin (p=4.19610
26) and rs13107325,
located upstream of NFKB1, was strongly associated with diastolic
blood pressure (p=7.53610
27), body mass index (p=1.37610
27),
high density lipoprotein levels (p=7.2610
211), and systolic blood
pressure (p=2.57610
27).
Discussion
Understanding the molecular basis of insulin resistance is
essential for the early diagnosis, treatment and prevention of T2D
and related co-morbidities, such as hyperlipidemia or cardiovas-
cular disease. In this study we explored the molecular basis of
insulin resistance beyond the known role of insulin signaling genes,
and, implicitly screened for novel candidate T2D genes. Based on
published evidence that connects the function of the mitochondria
with insulin resistance and T2D [5,47,48,49], we hypothesized
that there are genes responsible for the crosstalk between the
mitochondria and the insulin signaling system, which makes them
good candidates for T2D. By screening and filtering a variety of
available functional interaction data, we have first generated a
conservative network (MITIN) containing all genes involved in or
connected to the insulin signaling or mitochondrial systems, not
only through PPI but also based on interactions of other nature,
including co-expression, protein complexes, and signaling and
metabolic interactions. From there, we then selected a fraction of
286 internode genes that show connections to genes of both
systems and are, therefore, likely to be involved in the functional
crosstalk between the insulin signaling cascade and the mitochon-
dria.
We have examined these genes at different levels to validate
their bridging role and their potential implication in T2D or co-
morbidities. In order to provide a more stringent list amenable to
low throughput molecular biology experiments in future studies on
insulin resistance and diabetes, we ranked these genes on the basis
of their level of connectivity to insulin and mitochondrial genes
and generated a high confidence subset of 31 genes showing three
or more functional connections to each of the systems.
Mitochondria–Insulin Crosstalk T2D Candidate Genes
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PLOS Genetics | www.plosgenetics.org 10 December 2012 | Volume 8 | Issue 12 | e1003046While there are no reported confirmatory data for the majority
of the 286 internode genes, some have been already found to be
linked to both systems, and even to T2D and related metabolic
processes. For example TRAF2 [14,15,17,18], NFKB1
[19,20,21,22,23,24] (Figure 2) and SMAD3 [50], which show
multiple connections to insulin signaling and to mitochondrial
genes in our MITIN network, have also been described elsewhere
to interact with genes of both systems. In addition, variants near
the NFKB1 gene have been associated to T2D based on the
DIAGRAM dataset (best nearby SNP p-value=1.6610
25), while
SMAD3 has been recently found to protect against diet-induced
obesity as well as coronary artery disease [50,51]. Other genes that
also emerge as connecting internode genes in our MITIN network,
such as the chaperone HPSP90AA gene, have not been previously
described as linked to the insulin or the mitochondrial systems, but
have been linked to insulin resistance conditions and hence to
T2D [52,53].
On top of the previous knowledge on some of the internode
genes, we provide here further evidence that supports the
robustness of our search strategy and of this collection of genes
as potential molecular connectors of these systems, as well as
insulin resistance or T2D candidate genes. First, the 286 internode
genes showed significant enrichment of functional categories, like
‘‘regulation of beta cell development’’ (p=2.1610
279),‘ ‘ insulin synthesis
and secretion’’ (p=3.4610
279) and ‘‘diabetes pathways’’
(p=1.9610
235). Second, experimental models of mitochondria
and insulin signaling perturbation caused a significant upregula-
tion of the internode genes. This could be the result of direct
regulation or a mechanism that compensates these perturbed
metabolic scenarios. In all cases, the expression analyses helped us
to confirm that these genes are indeed functionally connected to
both systems. Furthermore, the deregulation of these internode
genes under experimental conditions of insulin resistance suggests
their involvement in T2D.
Encouraged by our positive functional and expression results
supporting the connecting role of the internode genes and their
impact on T2D, we went one step further and used the MITIN
network as a basis for the identification of genetic signatures
associated with T2D, contributing to unraveling its missing
heritability. We tested for enrichment of T2D associations within
the newly identified internode genes, by analyzing the results from
the DIAGRAM GWA meta-analyses [34] using MAGENTA to
define gene association scores and enrichment of gene associations
[35]. We found enrichment of T2D variants within this group of
genes, involving 18 associated genes compared to the 12 that were
expected by chance (p=0.0549). Our study also confirms the
absence of significant signal when we tested insulin signaling and
mitochondria gene-sets for enrichment of T2D associations. This
is in agreement with previous studies, where no enrichment was
found for mitochondrial or insulin signaling genes [34,35], and
suggests that the genes involved on the crosstalk between the
insulin and mitochondria networks are more susceptible to harbor
T2D risk variants than those that belong to either the insulin
cascade or the mitochondria alone. The best local SNP in each of
the 18 top ranked regions showed a combined risk score of
increased fasting glucose levels according to MAGIC consortium
data-sets (p=8.12610
25). Also supporting these results, several
variants in the internode genomic regions identified by MAGEN-
TA were also associated with many metabolic related quantitative
traits, as reported by the MAGIC [38,39,40,41,42], GIANT
[44,45] and ICBP [46] consortia (Table 2).
Interestingly, the best-associated SNP in four of the 18 genes
were among the 43 already validated loci of susceptibility for T2D,
which in the former reports were assigned to ZBED3, BCL11A,
PRC1, and KCNJ11 genes, based only in proximity [34,36,37].
Taking into account the intrinsic challenge in linking an associated
variant to its causal gene, we cannot exclude that these SNPs may
be proxies for causal variants affecting our group of identified
internode genes. Accordingly, recent findings suggest that a
fraction of regulatory variants can be more than 500 Kb away
from their regulated gene and that a single locus can expand more
than 1 Mb, and even contain more than one independent causal
variant [54,55,56]. Among the top 18 top ranked internode genes
identified by MAGENTA analyses of T2D GWAS meta-analysis,
there are independent lines of evidence suggesting the involvement
on the development of T2D or insulin resistance. For example,
two members of the IQ-motif-containing GTPase-activating
protein (IQGAP) family, scaffold proteins involved in a wide
range of cellular and signaling processes, including cytoskeletal
organization, cell adhesion, and tumorigenic processes [57,58],
appear in the top 95th percentile for association with T2D
according to MAGENTA analysis. IQ motif containing GTPase
activating protein 2 (IQGAP2), the second ranked gene according
to MAGENTA analysis, contained an intronic low frequency SNP
(rs6453220; MAF=0.05), which was strongly associated with
glycated haemoglobin according to MAGIC WGA-meta-analyses
(Hb1Ac; p=4.19610
26), providing more evidence that variants in
IQGAP2 may contribute to insulin resistance. In addition, another
gene of the same family, IQGAP1 (top four according to
MAGENTA), was recently reported to bind the target of
rapamycin complex 1 (mTORC1) having a potential negative
feedback loop role upstream mTORC1/S6K1 AKT1 activation
[59]. Furthermore, IQGAP1 associates with PKA and AKAP79 in
pancreatic Beta cells, suggesting a role in the Beta-cell develop-
ment and physiology [60]. It is also worth mentioning that
IQGAP1 was also found upregulated in our chronic insulin
treatment experiment (fold change 1.4; FDR,0.01) and the
Tp53inp2 RNAi treatment in myotubes experiment (fold
change=1.33; FDR=0.1). These results, together with the
general role of scaffolding proteins as hubs of signaling pathways
further supports the implication of the IQGAP protein family in
the insulin signaling and the mitochondrial systems crosstalk and
its association to T2D. RAB4A (Best SNP p value=3.5610
25)i sa
GTPase that regulates glucose transporter GLUT4 [61], and is
suggested to participate in metabolic remodeling in the diabetic
heart [62]. Finally, breast cancer anti-estrogen resistance 1
(BCAR1), (Best SNP p value=6.61610
25, distance from gen-
e=16.5 Kb) is another gene that deserves attention, as is
connected to 10 insulin genes, according to our network: CRK,
SRC, PTPN1, PTK2, CRKL, PIK3R1, GRB2, PTPRF, RHOA and
PTPRA. Interestingly, a SNP in an intronic region 16 Kb
upstream this gene was reported to be strongly associated with
type 1 diabetes [63].
In summary, this study contributes to untangling the molecular
basis linking the mitochondria and the insulin signaling systems
and provides a subset of novel T2D candidate genes for further
genetic, molecular and clinical studies. This study also constitutes a
proof of concept of the utility of combining several integrative
systems biology approaches with the analysis of gene expression
and large GWA meta-analyses to uncover novel associations with
complex diseases of otherwise hidden candidate genes.
Materials and Methods
Mitochondria and insulin parts lists
We constructed a consensus insulin pathway from several public
resources, including (Biocarta; www.biocarta.com, Kegg [12];
www.genome.jp/kegg/, and PID; [64]; http://pid.nci.nih.gov/)
Mitochondria–Insulin Crosstalk T2D Candidate Genes
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pathway was manually curated and refined by the participation
of molecular biologists in the field.
In order to select the parts lists that compose mitochondrial
proteins or genes, we have selected a total set of 900 proteins from
the mitoP2 database (www.mitop2.de/; [7]). As it was done for the
insulin pathway, the set has been manually curated by the
participation of the expert groups in the consortium.
To allow for transferability of the results to other species, we
have identified each mouse orthologous gene/protein for all
involved proteins.
Generation of the MITIN network
To identify protein-protein interactions we used a non-
redundant set of 23 protein interaction datasets and only included
those interactions reported independently by two different
laboratories (PPIhigh) [8].
For the gene co-expression analysis, we used the dataset of
Schadt et al. [9], which consists of expression data of 427 healthy
human liver samples and constituted the largest insulin-sensitive
human transcriptome dataset. We evaluated the overlap between
gene co-expression in liver and low confident PPIs (those reported
only by a single lab) to provide a new source of high confident
interactions.
Third, we added those interactions that pertained to the
CORUM complex database [10], considering that two genes are
functionally linked if they both pertain to a common complex.
The fourth source of interaction consisted of pairs of genes
coding for those enzymes that participate in linked (or consecutive)
metabolic reactions as described in KEGG or BiGG databases
[11,12,13].
Finally, we also considered those interactions between genes
coding for complexes or genes linked any signaling pathway, as
defined by KEGG [12].
Identification of enriched signatures
We used the Molecular Signatures Database from the Broad
Institute ([25]; http://www.broadinstitute.org/gsea/msigdb) and
for a total of 6770 gene sets, we computed an enrichment score
based on a Chi-Square test. The corrected significant p-value after
applying Bonferroni’s correction for all the tests was 4.41610
26.
We only considered gene sets that had at least 10 genes within the
group of internode genes.
Microarray data analysis and GSEA
All statistical analyses were performed using Bioconductor
(Gentleman et al., 2004). Microarray data was normalized via
quantile normalization and summarized to probeset expression
estimates via robust multi-array average (RMA) (Irizarry et al.,
2003) using the function rma from the oligo package. All the newly
generated data was deposited in the Gene Expression Omnibus
(GEO) (http://www.ncbi.nlm.nih.gov/geo) database (GSE3932).
We used gene set enrichment analysis (GSEA) (Subramanian et
al., 2005) as implemented in the Bioconductor library phenoTest
[65] to assess the degree of association between gene expression
and the following signatures: insulin, mitochondria and internodes.
As indicated in Subramanian et al. [25], P-values were computed
restricting attention to simulated ES with the same sign as ESobs.
Chronic insulin treatment
All chemicals and reagents were purchased from Sigma-Aldrich,
(Poole, UK). Briefly, C2C12 cells were cultured in Dulbecco’s
modified Eagle media (DMEM) supplemented with 10% Fetal
bovine serum, and penicillin/streptomycin. To induce differenti-
ation media was replenished by DMEM containing 2% (v/v) of
horse serum with penicillin/streptomycin. Myotubes between days
4 and 7 following the induction of differentiation were used for
experiments. For chronic insulin treatment cells were either left
untreated or incubated with 100 nMinsulin in DMEM for 48 h in
fusion medium to induce an insulin resistance state. Medium was
changed every 24 h.
Pgc1b knock-out model
Hearts were quickly collected and snap frozen in liquid nitrogen
from wild-type and PGC-1b KO on a mix background (sv129 and
C57BL/6) generated as previously reported [31]. Animal proce-
dures were performed in accordance with the UK Home Office
regulations and the UK Animal Scientific Procedures Act [A(sp)A
1986]. Animals were housed in a temperature-controlled room with
a 12-h light/dark cycle. Food and water were available ad libitum.
Dor silencing
Lentiviruses encoding scrambled or DOR siRNA were used as
reported [27]. Fifteen million C2C12 myoblasts grown on 12-well
plates were transduced at moi 100 and cells were amplified during
5–7 days. Transduced cells (GFP-positive) were then sorted with a
MoFlo flow cytometer (DakoCytomation, Summit v 3.1 software),
obtaining between 93%–99% GFP-positive cells. Confluent C2C12
myoblasts previously infected with lentiviruses encoding scrambled
RNA or DOR siRNA were allowed to differentiate in 5% horse
serum-containing medium for 4 days. Total RNA was purified and
microarrays were performed by using an Affimetrix platform.
Enrichment of T2D associations in internode genes
We used the latest DIAGRAM T2D GWA meta-analysis
comprising 8,130 cases and 38,987 controls [34] and the
MAGENTA software was used to test for enrichment of
associations in the 286 internode genes [35]. Briefly, we assigned
to each gene a set of SNPs that lie within 500 Kb upstream and
downstream of the gene’s most extreme transcript boundaries.
This boundaries were based on the fact that a fraction of
regulatory variants can be up to 500 Kb distal to their regulated
gene and that a single locus may harbor more than one causal
variants, and extend to more than 1 Mb from the locus top hit
[54,55,56]. For each gene, a score was assigned based on the most
significant SNP, followed by correction for confounders, including
gene size, number of independent SNPs, and linkage disequilib-
rium-based properties. Once all the association scores were
computed, MAGENTA tested for over-representation of genes
in a given gene set above a predetermined gene score rank cutoff,
which in this case was the 95th percentile of all gene scores. The
enrichment is evaluated against a null distribution of gene sets of
identical set size that were randomly sampled from the 6963 genes
that constitute our complete interactome based on all identified
functional interactions.
Risk score analyses using multi–SNP predictors in
glycemic traits from MAGIC consortium dataset
We computed how the best associated SNPs in the 18 regions
could collectively increase the risk of altered glycemic traits
available from MAGIC consortium datasets [38,39,40,41,42]. We
used the method described in [43]. An unweighted genetic risk
score was defined for each individual as the sum of the number of
risk increasing alleles at each of the 18 SNPs of interest. If one had
access to individual-level data, association between SNP score and
glycemic traits could be tested using the usual approach. However,
Mitochondria–Insulin Crosstalk T2D Candidate Genes
PLOS Genetics | www.plosgenetics.org 12 December 2012 | Volume 8 | Issue 12 | e1003046when the risk score involves SNPs in linkage equilibrium, it was
shown [43] that association between risk score and trait can be
assessed using meta-analysis results only, without going back to
individual-level data. The effect of the risk score on the phenotype
is estimated by
Pk
j~1 a2
j b bj bj
Pk
j~1 a2
j
, with standard error
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
Pk
j~1 a2
j
s
,
where b b bj is the meta analysis effect size for SNP j, and aj is the
inverse of the standard error estimate of b b bj.
The assumption of no Linkage Disequilibrium (LD) is required
for the contribution of each SNP to be independent and for the
standard error estimate to be valid. P-value for the risk score
association can be assessed using the ratio of the SNP score effect
estimate divided by its standard error, and assessing the
significance of the ratio by comparing it to the standard normal
distribution.
This large sample procedure will result in valid p-values under
the null hypothesis of no relationship between the trait and
variants included in the risk score.
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